WEBINAR

Scientific advances in 2025
to manage patients
with Advanced Systemic
Mastocytosis

An event organized by Blueprint Medicines, Switzerland GmbH
Dr Maël HEIBLIG,
Hematologist,
Expert at the CEREMAST
mastocytosis center
of excellence
Lyon Sud Hospital,
France
Dr Julien ROSSIGNOL, Hematologist,
Expert at the CEREMAST
national mastocytosis
center of excellence
Necker Hospital, Paris,
France
INT-BP-MED-NP-25010
FR-BP-MED-AVAASM-25010
BLU-MED-2025-015

LEGAL NOTICE

Home

Site publisher and owner: Santor Edition
SAS with capital of €250,000
Registered office: 65 rue d'Aguesseau, 92100 Boulogne Billancourt, France
Registered with the Nanterre Trade and Companies Register under number B500 480 652
VAT number FR1750048065200014
Telephone number: +33 (0)1 58 17 17 17
info@santor.net

This site is created, maintained and updated by Santor Edition, which also provides only technical management.

Editorial content is managed by Blueprint Medicines (France) SAS with capital of €25 000,
Registered office: 121 rue d’Aguesseau 92100 Boulogne-Billancourt (France)
Registered with the Nanterre Trade and Companies Register under number 878 672 021
VAT number FR44878672021.
Publication director: Mlle Katherine Compa

Site host: OVH
2 rue Kellermann
59100 Roubaix
France

We would like to take this opportunity to remind you that the treatment of personal data at Blueprint is taken seriously. If you would like to know more about our privacy practices, please consult our privacy policy at https://www.blueprintmedicines.com/privacy-policy/.
If you wish to exercise any of your privacy rights (access, rectification, suppression) regarding your personal data stored by Blue print please complete our form available here or send us an e-mail at EUprivacy@blueprintmedicines.com.
Legal notice | Privacy policy